Key result
Severe hypoglycemia is linked to increased cardiovascular events and mortality across type 1 and type 2 diabetes.
Severe hypoglycemia triggers pathophysiological changes that increase cardiovascular risk, reinforcing the clinical recommendation to minimize hypoglycemic episodes in patients with diabetes.
Severe hypoglycemia increases the risk of cardiovascular disease (CVD) in people with diabetes. Large cohort studies and scientific statements show that severe hypoglycemia is linked to higher rates of coronary heart disease, cardiovascular events, and mortality in both type 1 and type 2 diabetes. This risk is especially high in individuals with significant vascular risk, such as older adults and those with multiple cardiovascular risk factors. Hypoglycemia triggers several pathophysiological changes that increase cardiovascular risk. These include activation of the sympathoadrenal system, promotion of proinflammatory and prothrombotic states, arrhythmogenic changes, and increased hemodynamic stress. Experimental evidence shows that recurrent hypoglycemia worsens microvascular dysfunction and promotes adverse cardiac remodeling, especially in people with diabetes. While the link between hypoglycemia and cardiovascular events is well established, the causality remains debated. Hypoglycemia may directly contribute to cardiovascular disease or indicate underlying vulnerability, especially in patients with advanced disease or comorbidities. Minimizing hypoglycemic episodes is recommended for all patients with diabetes, particularly those with established cardiovascular disease, due to the clear association with adverse outcomes.
No takes yet. Share an insight, caveat, or question.
Karamfiloff et al. (2026) conducted a review in Type 1 and type 2 diabetes mellitus. Severe hypoglycemia was evaluated on Cardiovascular disease, coronary heart disease, cardiovascular events, and mortality. Severe hypoglycemia is linked to higher rates of coronary heart disease, cardiovascular events, and mortality in both type 1 and type 2 diabetes, though causality remains debated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: